written-consent-of-incorporator

Structures research consent documentation with required elements and vulnerable population protections. Use when creating research consents, managing consent processes, or documenting informed consent.

Evaluates informed consent practices against state law requirements and institutional policies. Use when auditing consent processes, reviewing consent form adequacy, or managing consent compliance.

Structures surgical consent documentation with procedure-specific risks, alternatives, and patient understanding. Use when obtaining surgical consent, documenting risk discussions, or verifying consent elements.

Structures informed consent documentation with risks, benefits, alternatives, and patient understanding confirmation. Use when obtaining informed consent, documenting consent discussions, or verifying consent completeness.

Drafts Written Consents in Lieu of Meeting for corporate boards or shareholders. Ensures compliance with state corporate law (e.g., DGCL §§141(f), 228), bylaws, and governing documents. Use when drafting board consent, shareholder consent, unanimous written consent, action by written consent, or consent in lieu of meeting.

Drafts U.S. corporate written-consent instruments (board, shareholder, member) as substitutes for formal meetings. Triggers when counsel requests board consent, shareholder written consent, unanimous consent, consent-in-lieu approvals, or "action without meeting" for contracts, financing, equity issuance, officer delegation, or governing-document amendments. Produces jurisdiction-aware approval records with threshold validation and execution mechanics.

Drafts dual-purpose telemedicine consent and policy documents covering informed consent, HIPAA privacy architecture, prescribing limitations, clinical scope boundaries, and patient acknowledgment sections. Addresses federal and state telehealth regulations, DEA controlled substance rules, and Interstate Medical Licensure Compact requirements. Use when drafting telehealth consent forms, telemedicine informed consent, remote patient monitoring agreements, virtual care policies, RPM consent documents, or store-and-forward authorization forms.

Drafts a Phase II invasive testing consent letter that limits scope, locations, timing, data control, restoration, security, and risk allocation under an existing access, due diligence, or purchase and sale agreement. Use this skill when a counterparty requests soil borings, test pits, groundwater wells, soil vapor sampling, or other intrusive ESA activities. Trigger on keywords including "Phase II," "invasive testing," "environmental site assessment," "ESA," "borings," "test pits," "monitoring wells," "restoration bond," "PLL insurance," "access agreement," "consent letter," "IDW handling," or "environmental due diligence." Even if the user just says "they want to do borings on the site" or "draft consent for Phase II," use this skill.

Drafts regulatory-compliant informed consent forms for healthcare procedures, clinical trials, research participation, or professional services. Incorporates HIPAA, FDA, IRB/Common Rule, and ICH-GCP requirements as applicable. Use when drafting surgical consent, research participant agreements, clinical trial consent, or treatment authorization forms.

Drafts an IRB-ready Informed Consent Form (ICF) for FDA-regulated clinical trials compliant with 21 CFR 50.25, 50.27, and ICH-GCP. Use when drafting or revising consent documents for Phase I–IV trials, IND studies, or other FDA-regulated protocols requiring IRB submission.

Drafts publication-ready cookie policies, banner copy, and consent-flow language under GDPR/ePrivacy, CCPA/CPRA, and major U.S. state privacy laws. Converts a verified cookie inventory into enforceable policy sections with lawful-basis mapping, granular opt-in controls, withdrawal mechanics, and user-rights handling. Use when asked for cookie policy, cookie banner, tracking notice, consent management, do-not-sell notice, or privacy rights messaging.

Drafts a Landlord's Consent to Sublease for commercial leasing transactions, producing recitals identifying the master lease and sublease, operative consent provisions, and protective conditions safeguarding landlord interests. Use when a tenant requests landlord approval to sublet premises, sublease consent, commercial subletting, or assignment of leasehold.